United Therapeutics AAQS 2024
United Therapeutics AAQS
9
Ticker
UTHR
ISIN
US91307C1027
WKN
923818
United Therapeutics has a current AAQS of 9.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock United Therapeutics in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
United Therapeutics Aktienanalyse
What does United Therapeutics do?
United Therapeutics Corporation, headquartered in Silver Spring, Maryland, is a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with rare and serious diseases. The company is a pioneer in creating life-saving therapies for a variety of conditions, including pulmonary hypertension, chronic lung failure, and lung cancer. United Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Frequently Asked Questions about United Therapeutics stock
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The United Therapeutics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von United Therapeutics
Our stock analysis for United Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of United Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- United Therapeutics Revenue
- United Therapeutics Net Income
- United Therapeutics P/E
- United Therapeutics P/S
- United Therapeutics EBIT
- United Therapeutics Dividend
- United Therapeutics Stocks
- United Therapeutics Market capitalization
- United Therapeutics Debt
- United Therapeutics Liabilities
- United Therapeutics Equity
- United Therapeutics AAQS
- United Therapeutics Employees
- United Therapeutics ROE
- United Therapeutics ROA
- United Therapeutics ROCE